Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 5, 2021Frontiers in MedicineOpen Access

Efficacy and Treatment-Related Adverse Events of Romidepsin in PTCL Clinical Studies: A Systematic Review and Meta-Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJun DuXHXinle HanSLSu-Wen Lin

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Du et al. (2021) studied this question.

synapsesocial.com/papers/69dbde1f7d378569a9836795https://doi.org/10.3389/fmed.2021.732727
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Peripheral T-cell lymphoma, not otherwise specified2017 · 108 citations
  2. 2<p>Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis</p>2019 · 37 citations
  3. 3Recent Advances in the Treatment of Peripheral T-Cell Lymphoma2018 · 57 citations
  4. 4Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation2015 · 13,518 citations
  5. 5Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy2012 · 683 citations